Marie C. Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marie C. Smith has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
John M. Davison
School of Surgical and Reproductive Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom; †Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico; and ‡Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, Florida
2 shared publicationsAlison P. Murdoch
1 shared publicationJm Davison
Department of Obstetrics and Gynaecology, School of Surgical and Reproductive Sciences, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
1 shared publicationJohn Davison
School of Surgical and Reproductive Sciences, University of Newcastle upon Tyne, NE2 4HH, UK
1 shared publicationKirk Conrad
Magee‐Womens Research Institute, Pittsburgh, Pensylvania 15213, USA
1 shared publicationKirk P. Conrad
1 shared publication
Latest Publications
- 5 November 2007
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 115 (1) , 109-112
Assessment of glomerular filtration rate during pregnancy using the MDRD formula
It is now recommended practice to use estimated glomerular filtration rate (eGFR) values to screen for and monitor chronic renal disease. The most frequently used formula in the general population is that described following the Modification of Diet in Renal Disease (MDRD) study whereby serum creatinine is adjusted for age, gender and race. This study evaluates the performance of the MDRD formula in pregnancy by comparing eGFR with measured values obtained by inulin clearance studies in early and late normal pregnancy and in pregnancies complicated by renal disease or pre‐eclampsia. Our results indicate that in all situations, MDRD substantially underestimates glomerular filtration rate during pregnancy and cannot be recommended for use in clinical practice.
- 5 November 2007
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 115 (1) , 109-112
Assessment of glomerular filtration rate during pregnancy using the MDRD formula
It is now recommended practice to use estimated glomerular filtration rate (eGFR) values to screen for and monitor chronic renal disease. The most frequently used formula in the general population is that described following the Modification of Diet in Renal Disease (MDRD) study whereby serum creatinine is adjusted for age, gender and race. This study evaluates the performance of the MDRD formula in pregnancy by comparing eGFR with measured values obtained by inulin clearance studies in early and late normal pregnancy and in pregnancies complicated by renal disease or pre‐eclampsia. Our results indicate that in all situations, MDRD substantially underestimates glomerular filtration rate during pregnancy and cannot be recommended for use in clinical practice.
- 1 November 2006
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 17 (11) , 3192-3197
Influence of Recombinant Human Relaxin on Renal Hemodynamics in Healthy Volunteers
Maternal renal hemodynamic adaptation to human pregnancy is one of the most dramatic of all physiologic changes, but the factors that are responsible have remained elusive. In rat pregnancy, there are comparable renal hemodynamic changes, and in this species there is comprehensive evidence that the ovarian hormone relaxin (RLX) is responsible. This study investigated the renal effects of recombinant human RLX (rhRLX) in humans. Eleven volunteers (six male, five female) received intravenous infusions of rhRLX over 5 h at an infusion rate that was chosen to sustain serum concentrations that are comparable to early pregnancy. The renal clearances of inulin and para-aminohippurate were used to measure GFR and renal plasma flow, respectively. Irrespective of gender, renal plasma flow was increased by 47% compared with baseline levels (P < 0.0001), but no significant change was observed in GFR. There were no side effects or adverse reactions of rhRLX given as an intravenous infusion, and the data suggest that RLX indeed may be one of the elusive renal vasodilatory factors in human pregnancy. Further work is necessary to elucidate the complimentary factors that permit the concomitant increase in GFR during pregnancy.
- 1 November 2006
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 17 (11) , 3192-3197
Influence of Recombinant Human Relaxin on Renal Hemodynamics in Healthy Volunteers
Maternal renal hemodynamic adaptation to human pregnancy is one of the most dramatic of all physiologic changes, but the factors that are responsible have remained elusive. In rat pregnancy, there are comparable renal hemodynamic changes, and in this species there is comprehensive evidence that the ovarian hormone relaxin (RLX) is responsible. This study investigated the renal effects of recombinant human RLX (rhRLX) in humans. Eleven volunteers (six male, five female) received intravenous infusions of rhRLX over 5 h at an infusion rate that was chosen to sustain serum concentrations that are comparable to early pregnancy. The renal clearances of inulin and para-aminohippurate were used to measure GFR and renal plasma flow, respectively. Irrespective of gender, renal plasma flow was increased by 47% compared with baseline levels (P < 0.0001), but no significant change was observed in GFR. There were no side effects or adverse reactions of rhRLX given as an intravenous infusion, and the data suggest that RLX indeed may be one of the elusive renal vasodilatory factors in human pregnancy. Further work is necessary to elucidate the complimentary factors that permit the concomitant increase in GFR during pregnancy.
- 1 July 2006
- Published by Elsevier in Fertility and Sterility
- Vol. 86 (1) , 253-255
Relaxin has a role in establishing a renal response in pregnancy
- 1 July 2006
- Published by Elsevier in Fertility and Sterility
- Vol. 86 (1) , 253-255
Relaxin has a role in establishing a renal response in pregnancy
- 1 May 2005
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1041 (1) , 163-172
Renal Hemodynamic Effects of Relaxin in Humans
Rat studies have convincingly demonstrated the essential role of the ovarian hormone relaxin in mediating gestational renal hemodynamic and osmoregulatory changes in that species. We describe a model in nonpregnant volunteers using exogenous hCG to stimulate the production and release of ovarian relaxin in order to assess renal hemodynamic responses. Women (n= .0) were serially studied ± hCG stimulation during menstrual cycles with measurement of inulin, PAH, and neutral dextran clearances (to determine glomerular filtration rate [GFR], renal plasma flow [RPF], and glomerular porosity, respectively). Controls were women without ovarian function (n= 6) and men (n= .0). GFR and RPF were increased in the luteal phase compared to the follicular phase (15.3% increase in GFR, P <0.005; 17.8% increase in RPF, P <0.05). In controls, GFR and RPF were not significantly different between study occasions. Although exogenous hCG did not stimulate relaxin secretion in women without ovarian function or in men, it did so in normal women, but not into the pregnancy range. In no group were renal hemodynamics augmented by administered hCG. In naturally occurring cycles, increased serum relaxin is associated with augmented renal hemodynamics. As luteal stimulation with hCG failed to yield pregnancy relaxin levels, the use of exogenous relaxin for human administration is needed to further elucidate the renal vasodilatory properties of relaxin.
- 1 May 2005
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1041 (1) , 163-172
Renal Hemodynamic Effects of Relaxin in Humans
Rat studies have convincingly demonstrated the essential role of the ovarian hormone relaxin in mediating gestational renal hemodynamic and osmoregulatory changes in that species. We describe a model in nonpregnant volunteers using exogenous hCG to stimulate the production and release of ovarian relaxin in order to assess renal hemodynamic responses. Women (n= .0) were serially studied ± hCG stimulation during menstrual cycles with measurement of inulin, PAH, and neutral dextran clearances (to determine glomerular filtration rate [GFR], renal plasma flow [RPF], and glomerular porosity, respectively). Controls were women without ovarian function (n= 6) and men (n= .0). GFR and RPF were increased in the luteal phase compared to the follicular phase (15.3% increase in GFR, P <0.005; 17.8% increase in RPF, P <0.05). In controls, GFR and RPF were not significantly different between study occasions. Although exogenous hCG did not stimulate relaxin secretion in women without ovarian function or in men, it did so in normal women, but not into the pregnancy range. In no group were renal hemodynamics augmented by administered hCG. In naturally occurring cycles, increased serum relaxin is associated with augmented renal hemodynamics. As luteal stimulation with hCG failed to yield pregnancy relaxin levels, the use of exogenous relaxin for human administration is needed to further elucidate the renal vasodilatory properties of relaxin.